Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Zingiber cassumunar (Phlai capsule) on bronchial hyperresponsiveness in asthmatic patients
TCTR20200305004Phase 2Completed
- Sponsor
- Government Pharmaceutical Organization
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zingiber cassumunar in asthma, airway hyperresponsiveness (AHR), sponsored by Government Pharmaceutical Organization. Started Feb 2019; status: completed.
02
Drugs
zingiber cassumunar
03
Conditions
asthmaairway hyperresponsiveness (AHR)
Beyond the preview
Go deeper on TCTR20200305004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200305004.